First Gene Editing Therapy Among Seven Drugs On Track For EU-Wide Approval

CHMP Confirms Non-Renewal Of Conditional Authorization For GSK’s Multiple Myeloma Drug

The European Medicines Agency has recommended seven new drugs for EU-wide approval, and OKd two others under its EU-M4all procedure that is meant for high-priority human medicines intended for markets outside the EU.

Casgevy Is A Personalized One-Off Treatment • Source: Shutterstock

The first CRISPR/Cas9 gene-editing therapy, Casgevy (exagamglogene autotemcel), is on track for pan-EU marketing approval as a treatment for sickle cell disease (SCD) and transfusion-dependent beta thalassemia (TBT) after receiving a thumbs up at the December meeting of the European Medicines Agency’s human medicines committee, the CHMP.

Casgevy is Vertex Pharmaceuticals/CRISPR Therapeutics’ cell-based gene therapy medicinal product that uses the novel CRISPR/Cas9 technology to edit...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Approvals

More from Product Reviews

  • data

    New EU Filings

     
    • By 

    <p>Executive Summary</p> <p>Zanidatamab, Jazz and BeiGene’s investigational treatment for biliary tract cancer, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.</p>

  • data

    EU CHMP Opinions And MAA Updates

     
    • By 

    <p>Executive Summary</p> This is an update of recommendations from the European Medicines Agency's Committee for Medicinal Products for Human Use on the authorization of new medicines in the EU, and updates on EU marketing authorization changes recommended by the CHMP.

  • EU Biosimilar Filings, Opinions And Approvals

     
    • By 

    <p>Executive Summary</p> <p>A list of EU biosimilar filings, CHMP opinions and EU marketing authorizations, including details of the biosimilar company, the brand name/INN, indication(s), the reference product/company, and the date and type of event.</p>